After active treatment, the five-year survival rate of middle and late stage stomach cancer patients is about 60%, which may vary.
Gastric cancer is a common malignant tumor, which may cause nausea and vomiting, blood in stool, abdominal pain and other clinical manifestations. Patients in middle and late stages need to undergo preoperative neoadjuvant chemotherapy and postoperative radiotherapy and other adjuvant treatments according to their conditions. After active treatment, patients can obtain a five-year survival rate of about 60%.
If the patient tolerates the treatment well, the outcome is relatively good. If the patient does not tolerate the treatment well, the outcome will be poor and the survival time will be significantly shortened. After the operation, regular review as prescribed by the doctor, maintaining good habits in daily life, and proper exercise can reduce the recurrence rate and prolong the survival period of patients to a certain extent.